Hertzliya, Israel · Health Care · Form D filed Aug 19, 2026
Intercure Ltd. filed a Form D
Intercure Ltd. is a pharmaceutical company based in Hertzliya, Israel. In a Form D filed with the SEC on August 19, 2026, it reported an offering of indefinite size with no sales completed at the time of filing. The first sale in the offering took place on June 15, 2026.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
$0 raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 19, 2026 | — | Open | 15 |
Lead score
22 out of 100
first raise ever website found
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- intercure.co
- Amount raised
- None reported yet
- Offering size
- Indefinite
- Investors so far
- 15
- First sale
- June 15, 2026
- Securities offered
- Equity, Options or warrants
- Exemption claimed
- Rule 506(b)
- Industry
- Pharmaceuticals
- Headquarters
- Hertzliya, Israel
- Incorporated
- Israel
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | — | Indefinite | 15 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 17, 2026 · August 2026 funding report
Similar raises
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
North Elam Ambulatory Surgery Center, LLC
Greensboro, NC · filed Oct 16First Form DStill raising
Immorta Bio, Inc.
Miami Beach, FL · filed Oct 162nd Form D since 2026Still raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
J3 Bioscience, Inc.
Salt Lake City, UT · filed Oct 1612th Form D since 2012
Ensho Therapeutics, Inc.
Woodcliff Lake, NJ · filed Oct 155th Form D since 2024Still raising
Light Wave Ownership Path, LLC
Raleigh, NC · filed Oct 1512th Form D since 2019
Immuno Cancer Biotherapeutics, Inc.
Canton, SD · filed Oct 15First Form D